Effects of Amidine Derivatives on Parasite-Macrophage Interaction and Evaluation of Toxicity

Summary In this work, the effect of amidine derivatives (with bromine and methoxy as substituents) in the “in vitro” parasite-macrophage interaction was evaluated. The potential toxicity was also analyzed. The results show that the methoxy-derivative was able to decrease the percentage of “in vitro” infection, being not hazardous to the host cell. Furthermore, experiments using Balb/c mice showed that this compound was very effective in avoiding infection in these animals. On the other hand, the compound with bromine as substituent was toxic to macrophages and unable to prevent infection in Balb/c mice. Pentamidine isethionate, used as reference drug, was not efficient in both experiments.

[1]  L. Leon,et al.  Effect of Amidine Derivatives on Leishmania amazonensis Axenic Amastigotes , 2000, Arzneimittelforschung.

[2]  A. Jansen,et al.  Amidine derivatives are highly effective against Trypanosoma evansi trypomastigotes. , 1999, Microbios.

[3]  I. Gilbert,et al.  Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase. , 1999, Journal of medicinal chemistry.

[4]  J. Berman.  Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Croft,et al.  Chemotherapy of human leishmaniasis and trypanosomiasis. , 1997 .

[6]  A. Jansen,et al.  The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi. , 1997, Microbios.

[7]  A. Echevarria,et al.  Synthesis, characterization, and anti-HIV activity of some 2-p-X-phenyl-1,3-N,N′-diphenyl-amidines , 1996 .

[8]  J. van Lunzen,et al.  Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani. , 1996, Archives of pathology & laboratory medicine.

[9]  M. Chance.  New developments in the chemotherapy of leishmaniasis. , 1995, Annals of tropical medicine and parasitology.

[10]  L. Goodwin.  Pentostam (sodium stibogluconate); a 50-year personal reminiscence. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  P. Hayes,et al.  Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  J. Alvar.  Leishmaniasis and AIDS co-infection: the Spanish example. , 1994, Parasitology today.

[13]  R. Pearson,et al.  Chemotherapy of leishmaniasis, Chagasʼ disease and African trypanosomiasis , 1993 .

[14]  A. Bryceson,et al.  Practical progress and new drugs for changing patterns of leishmaniasis. , 1993, Parasitology today.

[15]  G. Grimaldi júnior,et al.  Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. , 1992, Memorias do Instituto Oswaldo Cruz.

[16]  P. Desjeux,et al.  Estimation of population at risk of infection and number of cases of Leishmaniasis. , 1992, Parasitology today.

[17]  R. Badaró,et al.  Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. , 1991, The American journal of tropical medicine and hygiene.

[18]  G. Grimaldi júnior,et al.  Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  M. Kron,et al.  Pentamidine: a review. , 1985, Reviews of infectious diseases.

[20]  P. Marsden.  Pentavalent antimonials: old drugs for new diseases , 1985 .

[21]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.